Vaxcyte, Inc. - 8-K Filing
Vaxcyte issued $575M in convertible senior notes and raised ~$544.3M from equity offering on October 6-9, 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 8.01 Other Events, 9.01 Financial Statements and Exhibits)